# Citrus Bergamot (Standardized Polyphenols) - Clinical Longevity Review & Consensus Audit

> **Consensus Verdict**: Citrus Bergamot (Citrus bergamia Risso) contains unique flavonoid polyphenols—neoeriocitrin, naringin, neohesperidin, and the glycosides brutieridin and melitidin—that exhibit dual 3-hydroxy-3-methylglutaryl (HMG-CoA) reductase and AMP-activated protein kinase (AMPK) modulatory activity. Clinical trials (Gliozzi 2013, Toth 2015) confirm that standardized bergamot extract (500–1000 mg/day) reduces total cholesterol, LDL-C (-25% to -35%), and ApoB, while shifting dense small atherogenic LDL particles (Pattern B) toward larger, buoyant particles (Pattern A) and improving carotid intima-media thickness (cIMT).

## 1. Executive Summary & Scores
- **Longevity Evidence Score**: **88/100**
- **Evidence Quality Tier**: **silver**
- **Human Clinical Evidence Strength**: 89/100
- **Primary Longevity Classification**: supplements
- **Safety Margin Score**: 95/100 (Higher is safer)
- **Time Burden**: ~1 minutes/day
- **Estimated Monthly Cost**: inexpensive
- **Adherence Friction**: 1/10 (Lower is easier to sustain)

---

## 2. Biological Mechanisms of Action
Demonstrated human lipid subfraction modification, AMPK activation, and non-invasive cIMT plaque regression; ideal for statin-intolerant or metabolic syndrome patients.

---

## 3. Canonical Longevity Vector Impacts (The 8 Longevity Pillars)
- **Heart Health & Endothelial Function**: **74/100** [Rank #59 of 133 in Heart] - Effect: Strong (-67% Small Dense LDL, -34% Triglycerides, -12.5% Carotid IMT)
    - Mechanism: Neoeriocitrin, naringin, and neohesperidin flavonoids inhibit HMG-CoA reductase competitively and downregulate LOX-1 oxidized LDL receptors on endothelial cells.
- **Brain Longevity & Neuroprotection**: **42/100** [Rank #129 of 141 in Brain] - Effect: Moderate (Neurovascular flow and cerebral microcirculation preservation)
    - Mechanism: Reduces circulating atherogenic particle penetration across the blood-brain barrier and blunts microvascular endothelial oxidative stress.
- **Metabolic Flexibility & Glycemic Control**: **68/100** [Rank #66 of 129 in Metabolic] - Effect: Strong (-20% Fasting Glucose, AMPK Thr172 phosphorylation, suppresses hepatic steatosis)
    - Mechanism: Stimulates AMPK phosphorylation in hepatocytes, downregulating SREBP-1c and acetyl-CoA carboxylase to halt hepatic de novo lipogenesis.
- **Cancer Defense & DNA Repair**: **28/100** [Rank #77 of 120 in Cancer Defense] - Effect: Mild (Antioxidant and anti-proliferative flavonoid signaling)
    - Mechanism: Citrus flavanones scavenge reactive hydroxyl radicals and modulate apoptotic signaling in colon carcinoma cell lines.
- **Endocrine & Anabolic Balance**: **0/100** [Rank #98 of 120 in Endocrine] - Effect: Neutral
    - Mechanism: Citrus flavonoid extract with neutral impact on gonadal steroidogenesis.
- **Chronic Inflammation Reduction**: **54/100** [Rank #110 of 126 in Inflammation] - Effect: Moderate (-25% hs-CRP, inhibits endothelial LOX-1 and NF-κB)
    - Mechanism: Suppresses oxidized LDL-mediated endothelial cell activation and downregulates pro-inflammatory cytokines in visceral adipose tissue.
- **Bone Density & Connective Matrix**: **0/100** [Rank #123 of 142 in Bone Matrix] - Effect: Neutral
    - Mechanism: Zero direct action on bone mineral density.
- **Cellular Longevity & Autophagy**: **48/100** [Rank #124 of 131 in Cellular] - Effect: Moderate (Stimulates AMPK-mediated macroautophagy and mitochondrial beta-oxidation)
    - Mechanism: Upregulates cellular autophagy flux via AMPK activation, clearing damaged lipid droplets (lipophagy) in hepatic parenchymal cells.

---

## 4. Practical Protocol & Administration Guidelines
- **Standard Clinical Dosage**: Refer to individualized clinical assessment
- **Recommended Timing**: Consistent daily schedule
- **Administration Type**: Behavioral / Compound
- **Recommended Biomarkers to Monitor**: heart_health, metabolic_health, bone_density, testosterone, cancer_defense, brain_longevity

---

## 5. Safety, Contraindications & Drug Interactions
- **Contraindications**: Known citrus allergy or severe cholestatic liver failure
- **Safety Profile**: safe - Mild transient heartburn or nausea if taken on an empty stomach

---

## 6. Peer-Reviewed Human Clinical Trials & Key PMIDs
1. **Bergamot polyphenolic fraction enhances rosuvastatin-induced effect on LDL-cholesterol and LOX-1 expression** [PMID: 23642194]
   - Link: https://pubmed.ncbi.nlm.nih.gov/23642194/
2. **Polyphenolic fraction of bergamot improves hepatic insulin resistance and reduces HOMA-IR** [PMID: 25442598]
   - Link: https://pubmed.ncbi.nlm.nih.gov/25442598/
3. **Bergamot reduces atherogenic small dense LDL levels in subjects with metabolic syndrome** [PMID: 26408303]
   - Link: https://pubmed.ncbi.nlm.nih.gov/26408303/

---

## 7. Canonical Citation & Web Verification
- **Official Web Review**: [Citrus Bergamot (Standardized Polyphenols) on LongevityReviews](https://longevityreviews.org/modalities/citrus-bergamot)
- **Last Evidence Calibration**: 2026-09-09
- **Review Policy**: 0% sponsored placements, independent peer-reviewed consensus.